Wells Fargo’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-216
| Closed | – | – | 7732 |
|
|
2021
Q4 | $0 | Buy |
216
+198
| +1,100% | – | ﹤0.01% | 7629 |
|
|
2021
Q3 | $0 | Hold |
18
| – | – | ﹤0.01% | 7486 |
|
|
2021
Q2 | $0 | Sell |
18
-1,326
| -99% | – | ﹤0.01% | 7375 |
|
|
2021
Q1 | $4K | Sell |
1,344
-17,535
| -93% | -$52.2K | ﹤0.01% | 6192 |
|
|
2020
Q4 | $363K | Sell |
18,879
-2,839
| -13% | -$54.6K | ﹤0.01% | 4655 |
|
|
2020
Q3 | $292K | Buy |
21,718
+2,250
| +12% | +$30.3K | ﹤0.01% | 4596 |
|
|
2020
Q2 | $825K | Buy |
19,468
+5,558
| +40% | +$236K | ﹤0.01% | 3861 |
|
|
2020
Q1 | $384K | Sell |
13,910
-32
| -0.2% | -$883 | ﹤0.01% | 4106 |
|
|
2019
Q4 | $453K | Sell |
13,942
-688
| -5% | -$22.4K | ﹤0.01% | 4341 |
|
|
2019
Q3 | $381K | Buy |
14,630
+11,508
| +369% | +$300K | ﹤0.01% | 4432 |
|
|
2019
Q2 | $115K | Sell |
3,122
-679
| -18% | -$25K | ﹤0.01% | 5031 |
|
|
2019
Q1 | $84K | Sell |
3,801
-9
| -0.2% | -$199 | ﹤0.01% | 5098 |
|
|
2018
Q4 | $54K | Sell |
3,810
-25
| -0.7% | -$354 | ﹤0.01% | 5214 |
|
|
2018
Q3 | $74K | Buy |
3,835
+204
| +6% | +$3.94K | ﹤0.01% | 5205 |
|
|
2018
Q2 | $80K | Sell |
3,631
-237
| -6% | -$5.22K | ﹤0.01% | 5215 |
|
|
2018
Q1 | $82K | Buy |
+3,868
| New | +$82K | ﹤0.01% | 5137 |
|